{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:08:26Z","timestamp":1792188506473,"version":"4.4.0"},"reference-count":243,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-23-IAHU-0004"],"award-info":[{"award-number":["ANR-23-IAHU-0004"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jconrel.2025.114139","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T21:16:59Z","timestamp":1755551819000},"page":"114139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Nanoparticle-based approaches for sepsis treatment: Current trends and perspectives"],"prefix":"10.1016","volume":"386","author":[{"given":"Younes","family":"Louaguenouni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Mansart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djillali","family":"Annane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Fattal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/viru.27372","article-title":"Epidemiology of severe sepsis","volume":"5","author":"Mayr","year":"2014","journal-title":"Virulence"},{"issue":"17","key":"10.1016\/j.jconrel.2025.114139_bb0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.21037\/atm.2016.08.59","article-title":"Epidemiologic trends of sepsis in Western countries","volume":"4","author":"Suarez De La Rica","year":"2016","journal-title":"Ann. Transl. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114139_bb0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S2213-2600(18)30063-8","article-title":"The global burden of Paediatric and neonatal Sepsis: a systematic review","volume":"6","author":"Fleischmann-Struzek","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jconrel.2025.114139_bb0020","series-title":"Improving the Prevention, Diagnosis and Clinical Management of Sepsis Report by the Secretariat","year":"2025"},{"issue":"3","key":"10.1016\/j.jconrel.2025.114139_bb0025","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1021\/nn5057595","article-title":"Multivalent nanoparticle networks enable point-of-care detection of human phospholipase-A2 in serum","volume":"9","author":"Chapman","year":"2015","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114139_bb0035","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1039\/C8NR07769J","article-title":"Applications of nanoparticles in biomedical imaging","volume":"11","author":"Han","year":"2019","journal-title":"Nanoscale"},{"issue":"9","key":"10.1016\/j.jconrel.2025.114139_bb0040","doi-asserted-by":"crossref","first-page":"8557","DOI":"10.1021\/acsanm.0c01978","article-title":"Nanoparticle-based strategies to combat COVID-19","volume":"3","author":"Medhi","year":"2020","journal-title":"ACS Appl. Nano Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/btm2.10003","article-title":"Nanoparticles in the clinic","volume":"1","author":"Anselmo","year":"2016","journal-title":"Bioeng. Transl. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114139_bb0050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.mattod.2015.08.022","article-title":"Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: recent advances","volume":"19","author":"Revia","year":"2016","journal-title":"Mater. Today (Kidlington)"},{"issue":"12","key":"10.1016\/j.jconrel.2025.114139_bb0055","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3390\/biom9120773","article-title":"Liposomal cytarabine as cancer therapy: from chemistry to medicine","volume":"9","author":"Salehi","year":"2019","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.jconrel.2025.114139_bb0060","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date","volume":"33","author":"Bobo","year":"2016","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114139_bb0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae \u2014 the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","article-title":"Sixty years of amphotericin B: an overview of the Main antifungal agent used to treat invasive fungal infections","volume":"10","author":"Cavassin","year":"2021","journal-title":"Infect. Dis. Ther."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114139_bb0075","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114139_bb0080","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.immunol.26.021607.090326","article-title":"Monocyte-mediated defense against microbial pathogens","volume":"26","author":"Serbina","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114139_bb0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-pathol-011110-130327","article-title":"The pathogenesis of Sepsis","volume":"6","author":"Stearns-Kurosawa","year":"2011","journal-title":"Annu. Rev. Pathol."},{"issue":"suppl_1","key":"10.1016\/j.jconrel.2025.114139_bb0090","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/ajhp\/59.suppl_1.S3","article-title":"Pathophysiology of Sepsis","volume":"59","author":"Jacobi","year":"2002","journal-title":"Am. J. Heal. Pharm."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114139_bb0095","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0755-4982(04)98551-X","article-title":"Physiopathologie Du Sepsis S\u00e9v\u00e8re","volume":"33","author":"Caille","year":"2004","journal-title":"Presse Med."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114139_bb0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of Sepsis","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114139_bb0105","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114139_bb0110","series-title":"Causes of Late Mortality among ICU-Treated Patients with Sepsis","author":"Wilhelms","year":"2020"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/cc11152","article-title":"Drotrecogin alfa (activated) a sad final fizzle to a roller-coaster party","volume":"16","author":"Angus","year":"2012","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0120","first-page":"1","article-title":"Advancing Sepsis diagnosis and immunotherapy machine learning-driven identification of stable molecular biomarkers and therapeutic targets","volume":"15","author":"Xiong","year":"2025","journal-title":"Sci. Report."},{"issue":"8","key":"10.1016\/j.jconrel.2025.114139_bb0125","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jama.2017.0059","article-title":"Surviving sepsis guidelines","volume":"317","author":"De Backer","year":"2017","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jconrel.2025.114139_bb0130","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s12325-017-0622-8","article-title":"Sepsis: a review of advances in management","volume":"34","author":"Rello","year":"2017","journal-title":"Adv. Ther."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114139_bb0135","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00134-018-5085-0","article-title":"The surviving Sepsis campaign bundle: 2018 update","volume":"44","author":"Levy","year":"2018","journal-title":"Intensive Care Med."},{"issue":"8","key":"10.1016\/j.jconrel.2025.114139_bb0140","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for Sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jconrel.2025.114139_bb0145","doi-asserted-by":"crossref","first-page":"E1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit. Care Med."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114139_bb0150","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of Sepsis and potential therapeutic targets","volume":"17","author":"van der Poll","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0155","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4161\/viru.26516","article-title":"The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?","volume":"5","author":"Boomer","year":"2014","journal-title":"Virulence"},{"key":"10.1016\/j.jconrel.2025.114139_bb0160","article-title":"Sepsis: pathophysiology and clinical management","volume":"353","author":"Gotts","year":"2016","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.jconrel.2025.114139_bb0165","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0170","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12929-020-00702-6","article-title":"Advances in sepsis diagnosis and management: a paradigm shift towards nanotechnology","volume":"28","author":"Pant","year":"2021","journal-title":"J. Biomed. Sci."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114139_bb0175","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41551-018-0221-2","article-title":"Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates","volume":"2","author":"Lameijer","year":"2018","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0180","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/art.42665","article-title":"Liposomal AntagomiR-155-5p restores anti-inflammatory macrophages and Improves arthritis in preclinical models of rheumatoid arthritis","volume":"76","author":"Paoletti","year":"2024","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0185","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1038\/s41467-019-11911-5","article-title":"Genetic programming of macrophages to perform anti-tumor functions using targeted MRNA nanocarriers","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.jconrel.2025.114139_bb0190","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41578-022-00458-5","article-title":"Polymeric particle-based therapies for acute inflammatory diseases","volume":"7","author":"Brannon","year":"2022","journal-title":"Nat. Rev. Mater."},{"issue":"11","key":"10.1016\/j.jconrel.2025.114139_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014133","article-title":"High and increasing Oxa-51 DNA load predict mortality in Acinetobacter Baumannii bacteremia: implication for pathogenesis and evaluation of therapy","volume":"5","author":"Chuang","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0200","doi-asserted-by":"crossref","DOI":"10.1186\/s43162-021-00069-6","article-title":"Case report of a near-fatal case of Mycobacterium Massiliense Sepsis after de-clotting of an arteriovenous fistula","volume":"33","author":"Nawaz","year":"2021","journal-title":"Egypt. J. Intern. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0205","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/01.ccm.0000730776.27408.9a","article-title":"1222: Mycobacterium tuberculosis Sepsis a fatal mistake","volume":"49","author":"Pendkar","year":"2020","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.jconrel.2025.114139_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.675041","article-title":"Diagnosis of Mycobacterium tuberculosis septic shock in patients with anti-Synthetase syndrome based on next-generation sequencing: A case report and literature review","volume":"8","author":"Sun","year":"2021","journal-title":"Front. Med."},{"issue":"15","key":"10.1016\/j.jconrel.2025.114139_bb0215","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1080\/14656566.2021.1953472","article-title":"The role of amikacin in the treatment of nontuberculous mycobacterial disease","volume":"22","author":"Raaijmakers","year":"2021","journal-title":"Expert. Opin. Pharmacother."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114139_bb0220","doi-asserted-by":"crossref","first-page":"R165","DOI":"10.1186\/cc12844","article-title":"Therapeutic drug monitoring of amikacin in septic patients","volume":"17","author":"Duszynska","year":"2013","journal-title":"Crit. Care"},{"issue":"11","key":"10.1016\/j.jconrel.2025.114139_bb0225","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1023\/A:1011925132473","article-title":"Altered tissue distribution and elimination of amikacin encapsulated in Unilamellar, low-clearance liposomes (MiKasome)","volume":"15","author":"RM, F.; RO, L.; L, M.-M","year":"1998","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114139_bb0230","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/48.3.333","article-title":"Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies","volume":"48","author":"Schiffelers","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114139_bb0235","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41565-021-00866-8","article-title":"Nanotechnology approaches for global infectious diseases","volume":"16","author":"Kirtane","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114139_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279714","article-title":"Amikacin liposome and Mycobacterium Avium complex: A systematic review","volume":"17","author":"Zangiabadian","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0245","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s13346-018-00607-w","article-title":"Newly synthesized surfactants for surface Mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy","volume":"9","author":"Maretti","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2025.114139_bb0250","article-title":"Enhanced intracellular delivery and antibacterial efficacy of Enrofloxacin-loaded Docosanoic acid solid lipid nanoparticles against intracellular Salmonella","volume":"7","author":"Xie","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114139_bb0255","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13756-019-0504-8","article-title":"Doxycycline-encapsulated solid lipid nanoparticles as promising tool against Brucella Melitensis enclosed in macrophage: A pharmacodynamics study on J774A.1 cell line","volume":"8","author":"Hosseini","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control"},{"issue":"3","key":"10.1016\/j.jconrel.2025.114139_bb0260","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s13346-020-00849-7","article-title":"Inhalable solid lipid nanoparticles for intracellular tuberculosis infection therapy: macrophage-targeting and PH-sensitive properties","volume":"11","author":"Ma","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114139_bb0265","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/j.nano.2017.04.010","article-title":"Enhancing targeted antibiotic therapy via PH responsive solid lipid nanoparticles from an acid cleavable lipid","volume":"13","author":"Kalhapure","year":"2017","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2025.114139_bb0270","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijpharm.2018.08.025","article-title":"Synthesis of an oleic acid based PH-responsive lipid and its application in nanodelivery of vancomycin","volume":"550","author":"Mhule","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114139_bb0275","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3390\/nano11051251","article-title":"Incorporation of antibiotics into solid lipid nanoparticles: a promising approach to reduce antibiotic resistance emergence","volume":"11","author":"Arana","year":"2021","journal-title":"Nanomater. (Basel, Switzerland)"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2025.114139_bb0280","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijpharm.2007.11.035","article-title":"Antimicrobial effectiveness of liposomal Polymyxin B against resistant gram-negative bacterial strains","volume":"355","author":"Alipour","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114139_bb0285","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1172\/JCI7124","article-title":"Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia","volume":"104","author":"Kurahashi","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114139_bb0290","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/microorganisms7050138","article-title":"Community- and hospital-acquired Klebsiella Pneumoniae urinary tract infections in Portugal: virulence and antibiotic resistance","volume":"7","author":"Caneiras","year":"2019","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114139_bb0295","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/infdis\/171.4.938","article-title":"Efficacy of gentamicin or ceftazidime entrapped in liposomes with prolonged Blood circulation and enhanced localization in Klebsiella Pneumoniae-infected lung tissue","volume":"171","author":"Bakker-Woudenberg","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2025.114139_bb0300","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mib.2020.02.005","article-title":"Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms","volume":"53","author":"Kwiecinski","year":"2020","journal-title":"Curr. Opin. Microbiol."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114139_bb0305","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/BF01715542","article-title":"Enhanced killing of methicillin-Resistant Staphylococcus Aureus in human macrophages by liposome-entrapped vancomycin and Teicoplanin","volume":"22","author":"Onyeji","year":"1994","journal-title":"Infection"},{"issue":"3\u20134","key":"10.1016\/j.jconrel.2025.114139_bb0310","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1081\/LPR-200029887","article-title":"The delivery of benzyl penicillin to Staphylococcus Aureus Biofilms by use of liposomes","volume":"14","author":"Kim","year":"2004","journal-title":"J. Liposome Res."},{"issue":"11","key":"10.1016\/j.jconrel.2025.114139_bb0315","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3390\/polym11111758","article-title":"Synthesis, characterisation and biological evaluation of ampicillin-chitosan-Polyanion nanoparticles produced by ionic gelation and polyelectrolyte complexation assisted by high-intensity sonication","volume":"11","author":"Ciro","year":"2019","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.jconrel.2025.114139_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110388","article-title":"Self-assembled Oleylamine grafted hyaluronic acid Polymersomes for delivery of vancomycin against methicillin resistant Staphylococcus Aureus (MRSA)","volume":"182","author":"Walvekar","year":"2019","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"9","key":"10.1016\/j.jconrel.2025.114139_bb0325","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","article-title":"Amphotericin B formulations: a comparative review of efficacy and toxicity","volume":"73","author":"RJ, H","year":"2013","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.jconrel.2025.114139_bb0330","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0149-2918(03)80125-X","article-title":"A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations","volume":"25","author":"Barrett","year":"2003","journal-title":"Clin. Ther."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114139_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177093","article-title":"Weekly high-dose liposomal amphotericin B (L-AmB) in critically ill septic patients with multiple Candida colonization: the AmBiDex study","volume":"12","author":"Azoulay","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jconrel.2025.114139_bb0340","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/0003-4819-115-8-585","article-title":"Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy","volume":"115","author":"Chow","year":"1991","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114139_bb0345","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1128\/AAC.46.5.1481-1491.2002","article-title":"Bloodstream infections by extended-Spectrum Beta-lactamase-Producing Escherichia Coli and Klebsiella Pneumoniae in children: epidemiology and clinical outcome","volume":"46","author":"Kim","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2025.114139_bb0350","series-title":"Antibiotic Resistance is Making Neonatal Sepsis Harder to Treat","year":"2025"},{"key":"10.1016\/j.jconrel.2025.114139_bb0355","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fchem.2018.00204","article-title":"Antimicrobial peptides: interaction with model and biological membranes and synergism with chemical antibiotics","volume":"6","author":"Hollmann","year":"2018","journal-title":"Front. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0360","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/1568026615666150703121009","article-title":"Non-membrane Permeabilizing modes of action of antimicrobial peptides on Bacteria","volume":"16","author":"Scocchi","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114139_bb0365","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00063030-200317040-00002","article-title":"Cationic antimicrobial peptides","volume":"17","author":"Bradshaw","year":"2003","journal-title":"BioDrugs"},{"key":"10.1016\/j.jconrel.2025.114139_bb0370","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2147\/IJN.S218966","article-title":"Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas Aeruginosa infections","volume":"15","author":"Falciani","year":"2020","journal-title":"Int. J. Nanomedicine"},{"issue":"11","key":"10.1016\/j.jconrel.2025.114139_bb0375","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3390\/pharmaceutics11110588","article-title":"Advances in lipid and metal nanoparticles for antimicrobial peptide delivery","volume":"11","author":"Makowski","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114139_bb0380","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.msec.2019.04.023","article-title":"TRAIL encapsulated to polypeptide-crosslinked Nanogel exhibits increased anti-inflammatory activities in Klebsiella Pneumoniae-induced Sepsis treatment","volume":"102","author":"Chen","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2025.114139_bb0385","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fphar.2015.00249","article-title":"S-Thanatin functionalized liposome potentially Targeting on Klebsiella Pneumoniae and its application in Sepsis mouse model","volume":"6","author":"Fan","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"44","key":"10.1016\/j.jconrel.2025.114139_bb0390","doi-asserted-by":"crossref","first-page":"2407152","DOI":"10.1002\/adma.202407152","article-title":"Phase-separated Nano-antibiotics enhanced survival in multidrug-resistant Escherichia Coli Sepsis by precise periplasmic EcDsbA Targeting","volume":"36","author":"Zou","year":"2024","journal-title":"Adv. Mater."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114139_bb0395","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1128\/IAI.01958-14","article-title":"Severe Acinetobacter Baumannii Sepsis is associated with elevation of Pentraxin 3","volume":"82","author":"Ketter","year":"2014","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.jconrel.2025.114139_bb0400","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2016.162","article-title":"Combating multidrug-resistant gram-negative Bacteria with structurally Nanoengineered antimicrobial peptide polymers","volume":"1","author":"Lam","year":"2016","journal-title":"Nat. Microbiol."},{"issue":"20","key":"10.1016\/j.jconrel.2025.114139_bb0405","doi-asserted-by":"crossref","first-page":"7658","DOI":"10.3390\/ijms21207658","article-title":"Interactions of gold and silver nanoparticles with bacterial biofilms: molecular interactions behind inhibition and resistance","volume":"21","author":"Joshi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114139_bb0410","first-page":"451","article-title":"Zinc oxide nanoparticle reduced biofilm formation and antigen 43 expressions in uropathogenic Escherichia Coli, Iran","volume":"20","author":"Shakerimoghaddam","year":"2017","journal-title":"J. Basic Med. Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114139_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2022.102120","article-title":"Biosynthesized copper oxide nanoparticles (CuO NPs) enhances the anti-biofilm efficacy against K. pneumoniae and S. aureus","volume":"34","author":"Bai","year":"2022","journal-title":"J. King Saud Univ. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0420","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1080\/21691401.2019.1624560","article-title":"Ultrasound assisted-Phytofabricated Fe 3 O 4 NPs with antioxidant properties and antibacterial effects on growth, biofilm formation, and spreading ability of multidrug resistant bacteria","volume":"47","author":"Alavi","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114139_bb0425","doi-asserted-by":"crossref","first-page":"11033","DOI":"10.1038\/srep11033","article-title":"Enhancing the antimicrobial activity of natural extraction using the synthetic Ultrasmall metal nanoparticles","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114139_bb0430","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/410423","article-title":"The interaction of Bacteria with engineered nanostructured polymeric materials: a review","volume":"2014","author":"Armentano","year":"2014","journal-title":"Sci. World J."},{"issue":"16","key":"10.1016\/j.jconrel.2025.114139_bb0435","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.3390\/ma12162540","article-title":"Antimicrobial silver nanoparticles for wound healing application: Progress and future trends","volume":"12","author":"Paladini","year":"2019","journal-title":"Mater. (Basel, Switzerland)"},{"issue":"3","key":"10.1016\/j.jconrel.2025.114139_bb0440","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.nantod.2015.04.002","article-title":"Antibacterial activity of silver nanoparticles: a surface science insight","volume":"10","author":"Le Ouay","year":"2015","journal-title":"Nano Today"},{"issue":"9","key":"10.1016\/j.jconrel.2025.114139_bb0445","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1128\/AEM.01658-08","article-title":"Antimicrobial properties of a novel silver-silica nanocomposite material","volume":"75","author":"Egger","year":"2009","journal-title":"Appl. Environ. Microbiol."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114139_bb0450","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1128\/AEM.02218-06","article-title":"Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli","volume":"73","author":"Pal","year":"2007","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.jconrel.2025.114139_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.109968","article-title":"Antibacterial activity of ZnO and CuO nanoparticles against gram positive and gram negative strains","volume":"104","author":"Dadi","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0460","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jbm.b.31620","article-title":"Antibacterial activity of dental composites containing zinc oxide nanoparticles","volume":"94","author":"Aydin Sevin\u00e7","year":"2010","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"6","key":"10.1016\/j.jconrel.2025.114139_bb0465","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.nano.2016.02.006","article-title":"The antimicrobial activity of ZnO nanoparticles against Vibrio Cholerae: variation in response depends on biotype","volume":"12","author":"Sarwar","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"8","key":"10.1016\/j.jconrel.2025.114139_bb0470","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1021\/la7035949","article-title":"Toxicological effect of ZnO nanoparticles based on Bacteria","volume":"24","author":"Huang","year":"2008","journal-title":"Langmuir"},{"issue":"5","key":"10.1016\/j.jconrel.2025.114139_bb0475","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.mib.2011.08.003","article-title":"Combination therapies for combating antimicrobial resistance","volume":"14","author":"Fischbach","year":"2011","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.jconrel.2025.114139_bb0480","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.2147\/IJN.S49284","article-title":"Combined efficacy of biologically synthesized silver nanoparticles and different antibiotics against multidrug-resistant Bacteria","volume":"8","author":"Naqvi","year":"2013","journal-title":"Int. J. Nanomedicine"},{"issue":"3","key":"10.1016\/j.jconrel.2025.114139_bb0485","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.31302","article-title":"Enhancing the anti-enterococci activity of different antibiotics by combining with metal oxide nanoparticles","volume":"9","author":"Iram","year":"2016","journal-title":"Jundishapur J. Microbiol."},{"issue":"8","key":"10.1016\/j.jconrel.2025.114139_bb0490","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1128\/AEM.06513-11","article-title":"Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas Aeruginosa and Enterobacter Aerogenes and methicillin-resistant Staphylococcus aureus","volume":"78","author":"Brown","year":"2012","journal-title":"Appl. Environ. Microbiol."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114139_bb0495","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s11051-010-9900-y","article-title":"A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment","volume":"12","author":"Marambio-Jones","year":"2010","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.jconrel.2025.114139_bb0500","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12951-015-0110-8","article-title":"Magnetic separation-based Blood purification: a promising new Approach for the removal of disease-causing compounds?","volume":"13","author":"Herrmann","year":"2015","journal-title":"J. Nanobiotechnol."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114139_bb0505","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/adhm.201200358","article-title":"Endotoxin removal by magnetic separation-based Blood purification","volume":"2","author":"Herrmann","year":"2013","journal-title":"Adv. Healthc. Mater."},{"issue":"10","key":"10.1016\/j.jconrel.2025.114139_bb0510","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nm.3640","article-title":"An extracorporeal Blood-cleansing device for Sepsis therapy","volume":"20","author":"Kang","year":"2014","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114139_bb0515","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00134-015-3751-z","article-title":"Early use of Polymyxin B Hemoperfusion in patients with septic shock due to peritonitis: A multicenter randomized control trial","volume":"41","author":"DM, P.; J, G.; Y, L.; AC, L.; M, K.; B, V.; J, P.; O, J.-B.; L, M.-L.; M, J.; O, M.; R, C.; M, F.; E, K.; C, V.; S, C.; J, M.; R, R","year":"2015","journal-title":"Intensive Care Med."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114139_bb0520","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00134-017-5004-9","article-title":"Polymyxin B-immobilized Hemoperfusion and mortality in critically ill adult patients with Sepsis\/septic shock: A systematic review with Meta-analysis and trial sequential analysis","volume":"44","author":"T, F.; R, G.; Y, K.; TA, F.; R, F.; K, D.; JL, V.; D, P.; R, R.; C, R.; SM, B","year":"2018","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-018-2181-z","article-title":"Extracorporeal techniques for the treatment of critically ill patients with Sepsis beyond conventional Blood purification therapy: the promises and the pitfalls","volume":"22","author":"Ankawi","year":"2018","journal-title":"Crit. Care"},{"key":"10.1016\/j.jconrel.2025.114139_bb0530","doi-asserted-by":"crossref","first-page":"77","DOI":"10.21037\/jeccm.2018.09.05","article-title":"Blood purification in critically ill patients with Sepsis and septic shock","volume":"2","author":"Chiu","year":"2018","journal-title":"J. Emerg. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0535","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/pcmedi\/pbab005","article-title":"Blood purification for sepsis: an overview","volume":"4","author":"Zhang","year":"2025","journal-title":"Precis. Clin. Med."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114139_bb0540","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/ATVBAHA.106.136325","article-title":"High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans","volume":"27","author":"Birjmohun","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jconrel.2025.114139_bb0545","doi-asserted-by":"crossref","first-page":"w13781","DOI":"10.4414\/smw.2013.13781","article-title":"Pro- or anti-inflammatory role of Apolipoprotein A-1 in high-density Lipoproteins?","volume":"143","author":"Vuilleumier","year":"2013","journal-title":"Swiss Med. Wkly."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114139_bb0550","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1194\/jlr.M007401","article-title":"Ganglioside embedded in reconstituted lipoprotein binds cholera toxin with elevated affinity","volume":"51","author":"Bricarello","year":"2010","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0555","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nbt.3037","article-title":"Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice","volume":"33","author":"Henry","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114139_bb0560","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1473-3099(18)30805-3","article-title":"CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial","volume":"19","author":"Laterre","year":"2019","journal-title":"Lancet Infect. Dis."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114139_bb0565","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/clinids\/6.4.497","article-title":"A two-step mechanism for the interaction of re lipopolysaccharide with erythrocyte membranes","volume":"6","author":"Carr","year":"1984","journal-title":"Clin. Infect. Dis."},{"issue":"27","key":"10.1016\/j.jconrel.2025.114139_bb0570","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.jconrel.2025.114139_bb0575","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nnano.2013.54","article-title":"A biomimetic Nanosponge that absorbs pore-forming toxins","volume":"8","author":"Hu","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114139_bb0580","article-title":"Neutrophil membrane-mimicking Nanodecoys with intrinsic anti-inflammatory properties alleviate Sepsis-induced acute liver injury and lethality in a mouse Endotoxemia model","volume":"14","author":"Xiao","year":"2022","journal-title":"Mater. Today Bio"},{"issue":"43","key":"10.1016\/j.jconrel.2025.114139_bb0585","doi-asserted-by":"crossref","first-page":"11488","DOI":"10.1073\/pnas.1714267114","article-title":"Macrophage-like nanoparticles concurrently absorbing endotoxins and Proinflammatory cytokines for Sepsis management","volume":"114","author":"Thamphiwatana","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"22","key":"10.1016\/j.jconrel.2025.114139_bb0590","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay7148","article-title":"Treatment of severe Sepsis with nanoparticulate cell-free DNA scavengers","volume":"6","author":"Dawulieti","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.114139_bb0595","doi-asserted-by":"crossref","first-page":"113734","DOI":"10.1016\/j.jconrel.2025.113734","article-title":"In vivo delivery of antioxidant enzymes with multi-functionalized lipid nanoparticles for Sepsis therapy","volume":"382","author":"Koide","year":"2025","journal-title":"J. Control. Release"},{"issue":"1\u20133","key":"10.1016\/j.jconrel.2025.114139_bb0600","first-page":"34","article-title":"The role of cell-free plasma DNA in critically ill patients with Sepsis","volume":"41","author":"Clementi","year":"2015","journal-title":"Blood Purif."},{"issue":"11","key":"10.1016\/j.jconrel.2025.114139_bb0605","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1016\/j.matt.2021.09.001","article-title":"Targeting multiple mediators of Sepsis using multifunctional tannic acid-Zn2+-gentamicin nanoparticles","volume":"4","author":"Liu","year":"2021","journal-title":"Matter"},{"key":"10.1016\/j.jconrel.2025.114139_bb0610","doi-asserted-by":"crossref","first-page":"102430","DOI":"10.1016\/j.eclinm.2024.102430","article-title":"Efficacy and safety of phospholipid nanoparticles (VBI-S) in reversing intractable hypotension in patients with septic shock: a multicentre, open-label, repeated measures, phase 2a clinical pilot trial","volume":"68","author":"Simpkins","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"8","key":"10.1016\/j.jconrel.2025.114139_bb0615","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.ymthe.2018.05.019","article-title":"TLR4-binding DNA aptamers show a protective effect against acute stroke in animal models","volume":"26","author":"Fern\u00e1ndez","year":"2018","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114139_bb0620","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/vaccines5040034","article-title":"TLR4 signaling pathway modulators as potential therapeutics in inflammation and Sepsis","volume":"5","author":"Kuzmich","year":"2017","journal-title":"Vaccines"},{"issue":"6","key":"10.1016\/j.jconrel.2025.114139_bb0625","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/infdis\/jiu556","article-title":"CD28 homodimer Interface mimetic peptide acts as a preventive and therapeutic agent in models of severe bacterial Sepsis and gram-negative bacterial peritonitis","volume":"211","author":"Ramachandran","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.jconrel.2025.114139_bb0630","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S2213-2600(18)30265-0","article-title":"The role of glucocorticoids as adjunctive treatment for Sepsis in the modern era","volume":"6","author":"Marik","year":"2018","journal-title":"Lancet Respir. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114139_bb0635","doi-asserted-by":"crossref","first-page":"R231","DOI":"10.1186\/cc11895","article-title":"Randomized double-blind placebo-controlled trial of 40 Mg\/day of atorvastatin in reducing the severity of Sepsis in Ward patients (ASEPSIS trial)","volume":"16","author":"Patel","year":"2012","journal-title":"Crit. Care"},{"issue":"10","key":"10.1016\/j.jconrel.2025.114139_bb0640","doi-asserted-by":"crossref","first-page":"646","DOI":"10.4103\/ijccm.IJCCM_474_16","article-title":"The effects of atorvastatin on inflammatory responses and mortality in septic shock: a single-center, randomized controlled trial","volume":"21","author":"Singh","year":"2017","journal-title":"Indian J. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114139_bb0645","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S1473-3099(13)70001-X","article-title":"Immunosuppression in Sepsis: a novel understanding of the disorder and a new therapeutic Approach","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Lancet Infect. Dis."},{"issue":"10","key":"10.1016\/j.jconrel.2025.114139_bb0650","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe7853","article-title":"A modular approach toward producing nanotherapeutics targeting the innate immune system","volume":"7","author":"van Leent","year":"2021","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114139_bb0655","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.cell.2020.09.059","article-title":"Trained immunity-promoting nanobiologic therapy suppresses tumor growth and potentiates checkpoint inhibition","volume":"183","author":"Priem","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jconrel.2025.114139_bb0660","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.immuni.2018.09.008","article-title":"Inhibiting inflammation with myeloid cell-specific Nanobiologics promotes organ transplant acceptance","volume":"49","author":"Braza","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0665","first-page":"R15","article-title":"Omics of endothelial cell dysfunction in Sepsis","volume":"4","author":"Langston","year":"2022","journal-title":"Vasc. Biol. (Bristol, England)"},{"issue":"3","key":"10.1016\/j.jconrel.2025.114139_bb0670","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00441-014-1809-9","article-title":"Leukocyte recruitment in inflammation: basic concepts and new mechanistic insights based on new models and microscopic imaging technologies","volume":"355","author":"Leick","year":"2014","journal-title":"Cell Tissue Res."},{"issue":"26","key":"10.1016\/j.jconrel.2025.114139_bb0675","doi-asserted-by":"crossref","first-page":"15895","DOI":"10.1073\/pnas.2631433100","article-title":"Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo","volume":"100","author":"Sakhalkar","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.jconrel.2025.114139_bb0680","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1021\/acsbiomaterials.9b01289","article-title":"Model particulate drug carriers modulate leukocyte adhesion in human Blood flows","volume":"5","author":"Kelley","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114139_bb0685","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/jcmm.13112","article-title":"Neutrophil dysregulation during Sepsis: an overview and update","volume":"21","author":"Shen","year":"2017","journal-title":"J. Cell. Mol. Med."},{"issue":"10","key":"10.1016\/j.jconrel.2025.114139_bb0690","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1182\/blood-2016-09-741298","article-title":"Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice","volume":"129","author":"McDonald","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jconrel.2025.114139_bb0695","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.thromres.2011.10.013","article-title":"Sepsis, thrombosis and organ dysfunction","volume":"129","author":"Semeraro","year":"2012","journal-title":"Thromb. Res."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114139_bb0700","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s41565-022-01161-w","article-title":"Nanomedicine platform for Targeting activated neutrophils and neutrophil-platelet complexes using an \u03b1(1)-antitrypsin-derived peptide motif","volume":"17","author":"Cruz","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114139_bb0705","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jconrel.2025.02.050","article-title":"Archaea-inspired Deoxyribonuclease I liposomes prevent multiple organ dysfunction in Sepsis","volume":"380","author":"Li","year":"2025","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0710","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10717544.2019.1701141","article-title":"Neutrophils, as \u201cTrojan horses\u201d, participate in the delivery of Therapeutical PLGA nanoparticles into a tumor based on the chemotactic effect","volume":"27","author":"Hao","year":"2020","journal-title":"Drug Deliv."},{"issue":"42","key":"10.1016\/j.jconrel.2025.114139_bb0715","doi-asserted-by":"crossref","first-page":"28866","DOI":"10.1021\/acsnano.4c09054","article-title":"Neutrophil hitchhiking enhances liposomal dexamethasone therapy of Sepsis","volume":"18","author":"Mathur","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114139_bb0720","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2024.03.029","article-title":"In situ neutrophil apoptosis and macrophage efferocytosis mediated by Glycyrrhiza protein nanoparticles for acute inflammation therapy","volume":"369","author":"X, L.; X, O.; T, Z.; X, L.; Q, Q.; L, J.; Z, X.; F, Z.; T, T.; H, L.; C, Y.; L, K.; Z, Z","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114139_bb0725","first-page":"381","article-title":"Robust micelles formulation to improve systemic corticosteroid therapy in Sepsis in multiple healthcare systems","author":"Y, L.; Q, W.; T, B.; C, C.; E, L.; J, M.; D, C.; S, G.-D.; J, V.; N, T.; E, F.; F, F","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114139_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119333","article-title":"Cargo-less nanoparticles program Innate Immune cell responses to toll-like receptor activation","volume":"218","author":"Casey","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114139_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119987","article-title":"Targeted immunomodulation of inflammatory monocytes across the Blood-brain barrier by curcumin-loaded nanoparticles delays the progression of experimental autoimmune encephalomyelitis","volume":"245","author":"Lu","year":"2020","journal-title":"Biomaterials"},{"issue":"15","key":"10.1016\/j.jconrel.2025.114139_bb0740","doi-asserted-by":"crossref","first-page":"8223","DOI":"10.3390\/ijms22158223","article-title":"Modulation of Nrf2 and NF-\u039aB signaling pathways by naturally occurring compounds in relation to Cancer prevention and therapy. Are combinations better than single compounds?","volume":"22","author":"Krajka-Ku\u017aniak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114139_bb0745","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ijbiomac.2019.10.227","article-title":"Protective effects of astragalus polysaccharide nanoparticles on septic cardiac dysfunction through inhibition of TLR4\/NF-\u039aB signaling pathway","volume":"153","author":"Xu","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2025.114139_bb0750","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3389\/fphys.2019.01071","article-title":"The role of autophagy in Sepsis: protection and injury to organs","volume":"10","author":"Yin","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jconrel.2025.114139_bb0755","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.2147\/IJN.S215055","article-title":"SPIONs enhances IL-10-Producing macrophages to relieve Sepsis via Cav1-Notch1\/HES1-mediated autophagy","volume":"14","author":"Xu","year":"2019","journal-title":"Int. J. Nanomedicine"},{"issue":"8","key":"10.1016\/j.jconrel.2025.114139_bb0760","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41565-022-01137-w","article-title":"NAD(H)-loaded nanoparticles for efficient Sepsis therapy via modulating Immune and vascular homeostasis","volume":"17","author":"Ye","year":"2022","journal-title":"Nat. Nanotechnol."},{"issue":"303","key":"10.1016\/j.jconrel.2025.114139_bb0765","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aab3459","article-title":"Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation","volume":"7","author":"Spence","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.jconrel.2025.114139_bb0770","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114436","article-title":"Targeted delivery of a phosphoinositide 3-kinase \u03b3 inhibitor to restore organ function in Sepsis","volume":"13","author":"Press","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jconrel.2025.114139_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178006","article-title":"Novel GSDMD inhibitor GI-Y1 attenuates Sepsis-induced myocardial dysfunction by targeting Gasdermin D and inhibiting Gasdermin D-mediated Pyroptosis","volume":"1003","author":"Shi","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114139_bb0780","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1073\/pnas.1912012117","article-title":"Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood\u2013brain barrier","volume":"117","author":"Marcos-Contreras","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.jconrel.2025.114139_bb0785","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/CIRCRESAHA.117.311401","article-title":"Reactive oxygen species in metabolic and inflammatory signaling","volume":"122","author":"Forrester","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2025.114139_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102046","article-title":"Nanotherapies for Sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: new insight for treating COVID-19","volume":"45","author":"Chen","year":"2021","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114139_bb0795","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.21037\/jtd.2019.03.03","article-title":"Vitamin C alone does not improve treatment outcomes in mechanically ventilated patients with severe Sepsis or septic shock: A retrospective cohort study","volume":"11","author":"Ahn","year":"2019","journal-title":"J. Thorac. Dis."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114139_bb0800","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/cc2887","article-title":"N-acetylcysteine in clinical Sepsis: a difficult marriage","volume":"8","author":"Spapen","year":"2004","journal-title":"Crit. Care"},{"issue":"31","key":"10.1016\/j.jconrel.2025.114139_bb0805","doi-asserted-by":"crossref","first-page":"7915","DOI":"10.1016\/j.biomaterials.2012.07.024","article-title":"Cellular uptake and reactive oxygen species modulation of cerium oxide nanoparticles in human monocyte cell line U937","volume":"33","author":"Lord","year":"2012","journal-title":"Biomaterials"},{"issue":"38","key":"10.1016\/j.jconrel.2025.114139_bb0810","doi-asserted-by":"crossref","first-page":"11399","DOI":"10.1002\/anie.201704904","article-title":"Ceria\u2013Zirconia nanoparticles as an enhanced multi-antioxidant for sepsis treatment","volume":"56","author":"Soh","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2025.114139_bb0815","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s40820-021-00598-3","article-title":"Nanoplatforms for Sepsis management: rapid detection\/warning, pathogen elimination and restoring Immune homeostasis","volume":"13","author":"Luo","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.114139_bb0820","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.freeradbiomed.2024.12.022","article-title":"Selective nitric oxide redistribution by phospholipid nanoparticles: a novel strategy to mitigate massive nitric oxide release and prevent reperfusion injury in septic shock","volume":"227","author":"Sasse","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jconrel.2025.114139_bb0825","article-title":"Reactive-oxygen-species-scavenging nanomaterials for resolving inflammation","volume":"11","author":"Huang","year":"2021","journal-title":"Mater. Today. Bio"},{"issue":"10","key":"10.1016\/j.jconrel.2025.114139_bb0830","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.7150\/thno.33727","article-title":"Nanozyme-mediated catalytic nanotherapy for inflammatory bowel disease","volume":"9","author":"Zhao","year":"2019","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.jconrel.2025.114139_bb0835","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/jacs.6b11013","article-title":"Comprehensive insights into the multi-antioxidative mechanisms of melanin nanoparticles and their application to protect brain from injury in ischemic stroke","volume":"139","author":"Liu","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.114139_bb0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120986","article-title":"A bilirubin-derived nanomedicine attenuates the pathological cascade of pulmonary fibrosis","volume":"275","author":"Keum","year":"2021","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114139_bb0845","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1186\/cc10332","article-title":"The late phase of Sepsis is characterized by an increased microbiological burden and death rate","volume":"15","author":"Otto","year":"2011","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0850","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ccc.2017.08.007","article-title":"Management of sepsis-induced immunosuppression","volume":"34","author":"Venet","year":"2018","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.jconrel.2025.114139_bb0855","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.phrs.2016.07.019","article-title":"Immunotherapy: a promising approach to reverse Sepsis-induced immunosuppression","volume":"111","author":"Patil","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114139_bb0860","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","article-title":"Granulocyte\u2013macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression","volume":"180","author":"Meisel","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114139_bb0865","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98960","article-title":"Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial","volume":"3","author":"Francois","year":"2018","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.jconrel.2025.114139_bb0870","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nm0697-678","article-title":"Monocyte deactivation in septic patients: restoration by IFN-\u03b3 treatment","volume":"3","author":"D\u00f6cke","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.114139_bb0875","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jss.2016.08.099","article-title":"Anti-PD-L1 peptide improves survival in Sepsis","volume":"208","author":"Shindo","year":"2017","journal-title":"J. Surg. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114139_bb0880","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1189\/jlb.0110037","article-title":"Delayed administration of Anti-PD-1 antibody reverses immune dysfunction and improves survival during Sepsis","volume":"88","author":"Brahmamdam","year":"2010","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114139_bb0885","doi-asserted-by":"crossref","first-page":"675","DOI":"10.7150\/thno.64874","article-title":"\u03b2-Glucan-coupled superparamagnetic Iron oxide nanoparticles induce trained immunity to protect mice against Sepsis","volume":"12","author":"Pan","year":"2022","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.jconrel.2025.114139_bb0890","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41551-023-01050-0","article-title":"Resolving Sepsis-induced Immunoparalysis via trained immunity by Targeting Interleukin-4 to myeloid cells","volume":"7","author":"Schrijver","year":"2023","journal-title":"Nat. Biomed. Eng."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114139_bb0895","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/08830185.2014.889129","article-title":"The role of the liver in Sepsis","volume":"33","author":"Yan","year":"2014","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114139_bb0900","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1504223","article-title":"Mechanisms of Sepsis-induced acute liver injury: a comprehensive review","volume":"15","author":"Guo","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10020-022-00510-8","article-title":"The liver in Sepsis: molecular mechanism of liver failure and their potential for clinical translation","volume":"28","author":"Beyer","year":"2022","journal-title":"Mol. Med."},{"key":"10.1016\/j.jconrel.2025.114139_bb0910","article-title":"Liver injury in Sepsis: manifestations, mechanisms and emerging therapeutic strategies","volume":"16","author":"Xu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114139_bb0915","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2147\/IJN.S394802","article-title":"An overview of drug delivery nanosystems for Sepsis-related liver injury treatment","volume":"18","author":"Lu","year":"2023","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0920","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jemt.24691","article-title":"Fighting Sepsis-induced liver damage with biosynthesized silver nanoparticles","volume":"88","author":"AM, M.; MA, D.; AA, A. M.; S, S.; R, A.-G.; MI, A.; MS, A","year":"2025","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.jconrel.2025.114139_bb0925","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.biomaterials.2017.08.008","article-title":"Reactive oxygen species-responsive polymeric nanoparticles for alleviating Sepsis-induced acute liver injury in mice","volume":"144","author":"Chen","year":"2017","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.jconrel.2025.114139_bb0930","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41581-023-00683-3","article-title":"Sepsis-associated acute kidney injury: consensus report of the 28th acute disease quality initiative workgroup","volume":"19","author":"Zarbock","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0935","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.semnephrol.2015.01.005","article-title":"Emerging therapeutic targets of Sepsis-associated acute kidney injury","volume":"35","author":"Swaminathan","year":"2015","journal-title":"Semin. Nephrol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0940","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.112.198226","article-title":"Alkaline phosphatase as a treatment of Sepsis-associated acute kidney injury","volume":"344","author":"Peters","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"10","key":"10.1016\/j.jconrel.2025.114139_bb0945","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1021\/acsbiomaterials.4c01385","article-title":"Nanotechnology-based drug delivery systems for treating acute kidney injury","volume":"10","author":"Qin","year":"2024","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0950","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1021\/acsbiomaterials.4c01852","article-title":"Self-assembled Pt\/Honokiol nanomicelles for the treatment of Sepsis-associated acute kidney injury","volume":"11","author":"Liu","year":"2024","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.jconrel.2025.114139_bb0955","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.actbio.2024.01.036","article-title":"A DNA-based and bifunctional nanomedicine for alleviating multi-organ injury in Sepsis under diabetic conditions","volume":"177","author":"Li","year":"2024","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0960","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12951-022-01589-1","article-title":"Protection of zero-valent iron nanoparticles against Sepsis and septic heart failure","volume":"20","author":"Wang","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.114139_bb0965","article-title":"Red blood cell membrane-camouflaged PLGA nanoparticles loaded with basic fibroblast growth factor for attenuating Sepsis-induced cardiac injury","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2025.114139_bb0970","first-page":"313","article-title":"Melanin nanoparticles alleviate Sepsis-induced myocardial injury by suppressing Ferroptosis and inflammation","volume":"24","author":"C, L.; Q, Z.; H, T.; J, L.; S, Z.; C, F.; J, Z.; R, L.; Y, L.; R, L.; Y, Z.; Q, W.; Z, Q.; Y, S","year":"2022","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb0975","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-022-02464-4","article-title":"Sepsis-associated brain injury: underlying mechanisms and potential therapeutic strategies for acute and long-term cognitive impairments","volume":"19","author":"Sekino","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"10","key":"10.1016\/j.jconrel.2025.114139_bb0980","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nrneurol.2012.183","article-title":"Sepsis-associated encephalopathy","volume":"8","author":"Gofton","year":"2012","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114139_bb0985","doi-asserted-by":"crossref","DOI":"10.1002\/brx2.67","article-title":"Recent advances in the pathogenesis, diagnosis, and treatment of Sepsis-associated encephalopathy","volume":"2","author":"Wang","year":"2024","journal-title":"Brain-X"},{"key":"10.1016\/j.jconrel.2025.114139_bb0990","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12951-021-00796-6","article-title":"Gold nanoparticles reduce inflammation in cerebral microvessels of mice with Sepsis","volume":"19","author":"Di Bella","year":"2021","journal-title":"J Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.114139_bb0995","article-title":"The Hexapeptide functionalized gold nanoparticles protect against Sepsis-associated encephalopathy by forming specific protein Corona and regulating macrophage activation","volume":"32","author":"Song","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"41","key":"10.1016\/j.jconrel.2025.114139_bb1000","doi-asserted-by":"crossref","first-page":"28228","DOI":"10.1021\/acsnano.4c08157","article-title":"Biomimetic nanomodulator regulates oxidative and inflammatory stresses to treat Sepsis-associated encephalopathy","volume":"18","author":"Qu","year":"2024","journal-title":"ACS Nano"},{"issue":"43","key":"10.1016\/j.jconrel.2025.114139_bb1005","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201803618","article-title":"Bioresponsive nanoparticles targeted to infectious microenvironments for Sepsis management","volume":"30","author":"Zhang","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114139_bb1010","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jconrel.2020.02.030","article-title":"Inflammation-targeting polymeric nanoparticles deliver Sparfloxacin and tacrolimus for combating acute lung Sepsis","volume":"321","author":"Yang","year":"2020","journal-title":"J. Control. Release"},{"issue":"23","key":"10.1016\/j.jconrel.2025.114139_bb1015","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz5466","article-title":"Squalene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation in rodents","volume":"6","author":"Dormont","year":"2020","journal-title":"Sci. Adv."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114139_bb1020","doi-asserted-by":"crossref","first-page":"8551","DOI":"10.1021\/acsnano.3c00906","article-title":"A multifunctional nanoparticle mitigating cytokine Storm by scavenging multiple inflammatory mediators of Sepsis","volume":"17","author":"Li","year":"2023","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.jconrel.2025.114139_bb1025","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid nanoparticle systems for enabling gene therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114139_bb1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2021.100424","article-title":"Difference in the lipid nanoparticle technology employed in three approved SiRNA (Patisiran) and MRNA (COVID-19 vaccine) drugs","volume":"41","author":"Suzuki","year":"2021","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2025.114139_bb1035","first-page":"175","article-title":"Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases","author":"E, F.; F, F","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.jconrel.2025.114139_bb1040","article-title":"Inhibition of MiR-155 protects against LPS-induced cardiac dysfunction and apoptosis in mice","volume":"5","author":"Wang","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2025.114139_bb1045","doi-asserted-by":"crossref","first-page":"7321","DOI":"10.1038\/ncomms8321","article-title":"Exosome-delivered MicroRNAs modulate the inflammatory response to endotoxin","volume":"6","author":"Alexander","year":"2015","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb1050","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41467-020-20449-w","article-title":"Nanoparticle delivery of MicroRNA-146a regulates Mechanotransduction in lung macrophages and mitigates injury during mechanical ventilation","volume":"12","author":"Bobba","year":"2021","journal-title":"Nat. Commun."},{"issue":"27","key":"10.1016\/j.jconrel.2025.114139_bb1055","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301243","article-title":"A Cyclodextrin-based PH-responsive MicroRNA delivery platform Targeting polarization of M1 to M2 macrophages for Sepsis therapy","volume":"12","author":"Ding","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"19","key":"10.1016\/j.jconrel.2025.114139_bb1060","article-title":"Biomimetic immunosuppressive exosomes that inhibit cytokine storms contribute to the alleviation of sepsis (Adv. Mater. 19\/2022)","volume":"34","author":"Li","year":"2022","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114139_bb1065","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/SHK.0b013e318162cf17","article-title":"Bim SiRNA decreases lymphocyte apoptosis and improves survival in sepsis","volume":"30","author":"Schwulst","year":"2008","journal-title":"Shock"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114139_bb1070","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0022-2836(03)00181-5","article-title":"Gene silencing by systemic delivery of synthetic SiRNAs in adult mice","volume":"327","author":"S\u00f8rensen","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jconrel.2025.114139_bb1075","article-title":"Pulmonary delivery of SiRNA anti-TNF\u03b1-loaded lipid nanoparticles for rapid recovery in murine acute lung injury","author":"Wang","year":"2025","journal-title":"Adv. Healthc. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114139_bb1080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/SHK.0b013e318194bcee","article-title":"Targeted delivery of SiRNA to cell death proteins in Sepsis","volume":"32","author":"Brahmamdam","year":"2009","journal-title":"Shock"},{"key":"10.1016\/j.jconrel.2025.114139_bb1085","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jconrel.2021.06.022","article-title":"Down-regulation of TNF-\u03b1 via macrophage-targeted RNAi System for the treatment of acute inflammatory Sepsis","volume":"336","author":"Lee","year":"2021","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb1090","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"MRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Sign. Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114139_bb1095","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00134-009-1468-6","article-title":"Glucocorticoid receptor MRNA Levels are selectively decreased in neutrophils of children with Sepsis","volume":"35","author":"van den Akker","year":"2009","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb1100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41565-019-0600-1","article-title":"Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial Sepsis","volume":"15","author":"Hou","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114139_bb1105","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-bioeng-070620-033348","article-title":"In situ programming of CAR T cells","volume":"23","author":"Parayath","year":"2021","journal-title":"Annu. Rev. Biomed. Eng."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114139_bb1110","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1021\/acsnano.3c10109","article-title":"MRNA-laden lipid-nanoparticle-enabled in situ CAR-macrophage engineering for the eradication of multidrug-resistant bacteria in a Sepsis mouse model","volume":"18","author":"Tang","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb1115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-019-2372-2","article-title":"Heterogeneity in Sepsis: new biological evidence with clinical applications","volume":"23","author":"Leligdowicz","year":"2019","journal-title":"Crit. Care"},{"key":"10.1016\/j.jconrel.2025.114139_bb1120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, mechanisms and significance of macrophage plasticity","volume":"15","author":"Locati","year":"2019","journal-title":"Annu. Rev. Pathol."},{"issue":"September","key":"10.1016\/j.jconrel.2025.114139_bb1125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2022.10.006","article-title":"Interplay between mucus mobility and alveolar macrophage targeting of surface-modified liposomes","volume":"352","author":"Japiassu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114139_bb1130","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2023.102712","article-title":"Liposomes - human phagocytes interplay in whole blood: effect of liposome design","volume":"54","author":"Giambelluca","year":"2023","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114139_bb1135","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112163","article-title":"Targeting MTOR in myeloid cells prevents infection-associated inflammation","volume":"28","author":"Toner","year":"2025","journal-title":"iScience"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114139_bb1140","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S2213-2600(23)00330-2","article-title":"Profiling the dysregulated Immune response in Sepsis: overcoming challenges to achieve the goal of precision medicine","volume":"12","author":"Cajander","year":"2024","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114139_bb1145","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-066496","article-title":"Rapid REcognition of COrticosteRoiD resistant or sensitive Sepsis (RECORDS): study protocol for a multicentre, placebo-controlled, biomarker-guided, adaptive Bayesian design basket trial","volume":"13","author":"Fleuriet","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.jconrel.2025.114139_bb1150","first-page":"245","article-title":"Corticosteroid sensitivity detection in Sepsis patients using a personalized data mining Approach: A clinical investigation","author":"R, H.; Z, C. D.; A, K.; K, Z.; D, A","year":"2024","journal-title":"Comput. Methods Prog. Biomed."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114139_bb1155","article-title":"Sepsis in silico: definition, development and application of an electronic phenotype for Sepsis","volume":"74","author":"Z, A.-S.; TJ, I.; B, M.; E, T.; M, R","year":"2025","journal-title":"J. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb1160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-025-00830-9","article-title":"Comparison of different AI systems for diagnosing sepsis, septic shock, and cardiogenic shock: a retrospective study","volume":"15","author":"Obmann","year":"2025","journal-title":"Sci. Report."},{"issue":"11","key":"10.1016\/j.jconrel.2025.114139_bb1165","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-024-01256-w","article-title":"Amine Headgroups in Ionizable lipids drive Immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d","volume":"8","author":"Chaudhary","year":"2024","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb1170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.29245\/2578-3009\/2021\/1.1206","article-title":"The impact of nanoparticles on the immune system: a gray zone of nanomedicine","volume":"5","author":"Ray","year":"2021","journal-title":"J. Immunol. Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114139_bb1175","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1804","article-title":"Immunotoxicity of nanomaterials in health and disease: current challenges and emerging approaches for identifying immune modifiers in susceptible populations","volume":"14","author":"Hofer","year":"2022","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114139_bb1180","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s13346-020-00740-5","article-title":"Challenges in nanomedicine clinical translation","volume":"10","author":"Metselaar","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb1185","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13613-019-0543-6","article-title":"Preclinical septic shock research: Why we need an animal ICU","volume":"9","author":"Guillon","year":"2019","journal-title":"Ann. Intensive Care."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114139_bb1190","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/SHK.0000000000001212","article-title":"Minimum quality Threshold in pre-clinical Sepsis studies (MQTiPSS): an international expert consensus initiative for improvement of animal Modeling in Sepsis","volume":"50","author":"MF, O.; A, A.; S, B.; M, B.; M, B.; JM, C.; IH, C.; CM, C.; CS, D.; S, D.; P, E.; C, F.; G, F.; W, G.; J, H.; M, H.-L.; S, I.; S, K.; AV, K.; C, L.; JC, M.; LL, M.; P, R.; H, R.; DG, R.; M, S.; C, T.; P, W.; WJ, W.; X, X.; B, Z","year":"2018","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb1195","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/SHK.0000000000001243","article-title":"Part I: minimum quality threshold in pre-clinical sepsis studies (MQTiPSS) for study design and humane modeling endpoints","volume":"51","author":"Zingarelli","year":"2019","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb1200","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/SHK.0000000000001242","article-title":"Part II: minimum quality threshold in preclinical sepsis studies (MQTiPSS) for types of infections and organ dysfunction endpoints","volume":"51","author":"C, L.; A, A.; M, B.; JM, C.; C, D.; C, F.; S, K.; AV, K.; P, W.; MF, O.; DG, R","year":"2019","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114139_bb1205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/SHK.0000000000001209","article-title":"Part III: minimum quality threshold in preclinical sepsis studies (MQTiPSS) for fluid resuscitation and antimicrobial therapy endpoints","volume":"51","author":"J, H.; S, B.; M, B.; IH, C.; G, F.; W, G.; S, I.; P, R.; M, S.; MF, O.; M, H.-L","year":"2019","journal-title":"Shock"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114139_bb1210","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201810128","article-title":"Sepsis therapies: learning from 30 years of failure of translational research to propose new leads","volume":"12","author":"Cavaillon","year":"2020","journal-title":"EMBO Mol. Med."},{"issue":"11","key":"10.1016\/j.jconrel.2025.114139_bb1215","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/s41565-024-01754-7","article-title":"A translational framework to DELIVER nanomedicines to the clinic","volume":"19","author":"Joyce","year":"2024","journal-title":"Nat. Nanotechnol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925007503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925007503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T08:41:10Z","timestamp":1777192870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925007503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":243,"alternative-id":["S0168365925007503"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114139","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticle-based approaches for sepsis treatment: Current trends and perspectives","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114139"}}